![]() |
![]() |
![]() |
![]() |
![]() |
---|---|---|---|---|
Health Care |
Federal
HHS |
02-16-2024 | N/A | No Match Required |
93.233 -- National Center on Sleep Disorders Research
93.837 -- Cardiovascular Diseases Research
93.838 -- Lung Diseases Research
93.839 -- Blood Diseases and Resources Research
93.840 -- Translation and Implementation Science Research for Heart, Lung, Blood Diseases, and Sleep Disorders
The National Heart, Lung and Blood Institute (NHLBI) intends to publish a reissue of the notice of funding opportunity (NOFO) PAR-21-079 NHLBI Clinical Trial Pilot Studies (R34 Clinical Trial Optional). This Notice is being provided to allow potential applicants sufficient time to develop meaningful collaborations and responsive projects.� The NOFO is expected to be published in Winter, 2023 with an expected application due date in February 2024. This NOFO will utilize the R34 activity code. Details of the planned NOFO are provided below.
How would you rate your overall experience on our website?
How easy is it to find the information you need?
How do you rate the look & feel of our website?
How could we improve our website?